KLK4 overexpression has been reported to be associated with prostate cancer stage, although the direction of effect differed for KLK4 mRNA (associated with advanced stage) [6] versus KLK4 protein (early stage tumours) [15]. The gene discussed is KLK4; the disease is prostate carcinoma.